Kercheville Advisors, LLC Johnson & Johnson Transaction History

Kercheville Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$168.19 - $186.01 $302,742 - $334,818	-1,800 Reduced 60.3%	1,185 $210,000
Q1 2022 Apr 29, 2022	SELL	$158.14 - $179.59 $3,953 - $4,489	-25 Reduced 0.83%	2,985 $529,000
Q4 2021 Jan 26, 2022	BUY	$155.93 - $173.01 $27,287 - $30,276	175 Added 6.17%	3,010 $515,000
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $21,318 - $23,690	-132 Reduced 4.45%	2,835 $458,000
Q2 2021 Nov 15, 2021	SELL	$159.48 - $171.07 $63,473 - $68,085	-398 Reduced 11.83%	2,967 $489,000
Q1 2021 Nov 15, 2021	SELL	$153.07 - $170.48 $13,010 - $14,490	-85 Reduced 2.46%	3,365 $552,000
Q4 2020 Nov 12, 2021	BUY	$137.11 - $157.38 $473,029 - $542,961	3,450 New	3,450 $543,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.